Entrada Therapeutics, Inc. (TRDA) stock
TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.03+0.07 (+1.41%)
Close on Nov 18, 2026Market cap $195.85MP/E –Yield –
Entrada Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Entrada Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$134.35M. For fiscal 2025 it was -$129.55M. The highest annual figure on record is $134.19M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$129.55M | – |
| FY2024 | Dec 31, 2024 | -$44.72M | -133.3% |
| FY2023 | Dec 31, 2023 | $134.19M | – |
| FY2022 | Dec 31, 2022 | -$96.67M | – |
| FY2021 | Dec 31, 2021 | -$55.44M | – |
| FY2020 | Dec 31, 2020 | -$27.89M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$32.47M | – |
| Q1 FY2026 | Mar 31, 2026 | -$41.74M | – |
| Q4 FY2025 | Dec 31, 2025 | -$32.00M | – |
| Q3 FY2025 | Sep 30, 2025 | -$28.14M | – |
| Q2 FY2025 | Jun 30, 2025 | -$29.76M | -176.7% |
| Q1 FY2025 | Mar 31, 2025 | -$39.65M | – |
| Q4 FY2024 | Dec 31, 2024 | -$32.24M | – |
| Q3 FY2024 | Sep 30, 2024 | -$24.91M | – |
| Q2 FY2024 | Jun 30, 2024 | $38.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$26.36M | -113.1% |
| Q4 FY2023 | Dec 31, 2023 | -$4.99M | – |
| Q3 FY2023 | Sep 30, 2023 | -$25.94M | – |
| Q2 FY2023 | Jun 30, 2023 | -$36.61M | – |
| Q1 FY2023 | Mar 31, 2023 | $201.73M | – |
| Q4 FY2022 | Dec 31, 2022 | -$28.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$28.29M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.78M | – |
| Q1 FY2022 | Mar 31, 2022 | -$21.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$21.86M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.45M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.24M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.07M | – |
See a number that looks wrong?